Two phase III trials of tauromustine (TCNU) in advanced colorectal cancer

Ann Oncol. 1995 Nov;6(9):948-9. doi: 10.1093/oxfordjournals.annonc.a059365.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase III
  • Comparative Study
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / therapeutic use*
  • Colorectal Neoplasms / drug therapy*
  • Colorectal Neoplasms / pathology
  • Female
  • Fluorouracil / administration & dosage
  • Fluorouracil / therapeutic use*
  • Humans
  • Male
  • Middle Aged
  • Nitrosourea Compounds / administration & dosage
  • Nitrosourea Compounds / adverse effects
  • Nitrosourea Compounds / therapeutic use*
  • Prognosis
  • Quality of Life
  • Regression Analysis
  • Survival Rate
  • Taurine / administration & dosage
  • Taurine / adverse effects
  • Taurine / analogs & derivatives*
  • Taurine / therapeutic use
  • Treatment Failure

Substances

  • Antineoplastic Agents
  • Nitrosourea Compounds
  • Taurine
  • 1-(2-chloroethyl)-3-(2-(dimethylaminosulfonyl)ethyl)-1-nitrosourea
  • Fluorouracil